Patents by Inventor Matthew E. O'Connor

Matthew E. O'Connor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11136678
    Abstract: Disclosed are methods for the electrochemical oxidation of a C—H bond in a compound to give a C—O bond or C—S bond. The oxidation of methane to methanol is described, as well as an electrochemical cell for performing the reaction.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: October 5, 2021
    Assignee: Massachusetts Institute of Technology
    Inventors: Yogesh Surendranath, Matthew E. O'Reilly
  • Patent number: 11005108
    Abstract: Disclosed are surface immobilized (electro)catalysts that may be prepared by a condensation reaction that generates an aromatic unit that is robust to acid and base and elevated temperatures. Among their many desirable characteristics, the catalysts are far less prone to the bimolecular deactivation pathways commonly observed for homogeneous catalysts, and may be used in solvents with a range of polarities and dielectric strengths. The catalysts are suitable for a wide array of thermal catalytic reactions (polymerization, oxidation, hydrogenation, cross-coupling etc.) and as anodes and/or cathodes in fuel cells, electrolyzers, and in batteries and supercapacitors.
    Type: Grant
    Filed: August 15, 2016
    Date of Patent: May 11, 2021
    Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Yogesh Surendranath, Tomohiro Fukushima, Matthew E. O'Reilly, Seokjoon Oh, Alexander T. Murray, Corey Jarin Kaminsky, Sterling Ben Chu, Megan N. Jackson
  • Publication number: 20190186026
    Abstract: Disclosed are methods for the electrochemical oxidation of a C—H bond in a compound to give a C—O bond or C—S bond. The oxidation of methane to methanol is described, as well as an electrochemical cell for performing the reaction.
    Type: Application
    Filed: August 11, 2017
    Publication date: June 20, 2019
    Inventors: Yogesh Surendranath, Matthew E. O'Reilly
  • Patent number: 10111679
    Abstract: An electronic system for a surgical instrument is disclosed. The electronic system comprises a main power supply circuit configured to supply electrical power to a primary circuit, a supplementary power supply circuit configured to supply electrical power to a secondary circuit, and a sleep mode monitor coupled between the main power supply circuit and the supplementary power supply circuit. The sleep mode monitor is configured to indicate one or more sleep mode conditions. The electronic system further comprises a device state monitor coupled to the primary circuit, the device state monitor configured to sense a state of various electrical and mechanical subsystems of the surgical instrument.
    Type: Grant
    Filed: September 5, 2014
    Date of Patent: October 30, 2018
    Assignee: Ethicon LLC
    Inventors: Daniel L. Baber, Jeffrey S. Swayze, Andrew T. Beckman, Christopher C. Miller, Charles J. Scheib, Jamison J. Float, Matthew E. O'Kelly
  • Patent number: 9896730
    Abstract: The present invention provides diagnostic methods for assessing the EMT status of tumor cells, and for predicting the effectiveness of treatment of a cancer patient with an EGFR or IGF-1R kinase inhibitor, utilizing an EMT gene signature index score. The present invention further provides methods for treating patients with cancer that incorporate these methods.
    Type: Grant
    Filed: April 25, 2012
    Date of Patent: February 20, 2018
    Assignees: OSI Pharmaceuticals, LLC, AVEO PHARMACEUTICALS, INC.
    Inventors: Julie Kan, Stuart Thomson, Gretchen M. Argast, Matthew E. O'Connor, Murray Robinson, Bin Feng, Joerg Heyer, Maria I. Chiu, Richard Nicoletti
  • Publication number: 20170047592
    Abstract: Disclosed are surface immobilized (electro)catalysts that may be prepared by a condensation reaction that generates an aromatic unit that is robust to acid and base and elevated temperatures. Among their many desirable characteristics, the catalysts are far less prone to the bimolecular deactivation pathways commonly observed for homogeneous catalysts, and may be used in solvents with a range of polarities and dielectric strengths. The catalysts are suitable for a wide array of thermal catalytic reactions (polymerization, oxidation, hydrogenation, cross-coupling etc.) and as anodes and/or cathodes in fuel cells, electrolyzers, and in batteries and supercapacitors.
    Type: Application
    Filed: August 15, 2016
    Publication date: February 16, 2017
    Inventors: Yogesh Surendranath, Tomohiro Fukushima, Matthew E. O'Reilly, Seokjoon Oh, Alexander T. Murray, Corey Jarin Kaminsky, Sterling Ben Chu, Megan N. Jackson
  • Publication number: 20160066912
    Abstract: An end effector is disclosed. The end effector comprises a first jaw member comprising a magnetic sensor; a second jaw member pivotally coupled to the first jaw member such that the first jaw member is pivotally moveable between an open position and a closed position, wherein the second jaw member is configured to receive a staple cartridge therein; a staple cartridge removably coupled to the second jaw member, the staple cartridge further comprising an upper surface facing the first jaw member; and a magnet positioned to be in an opposing relationship to the magnetic sensor when the first jaw member is in the closed position. The magnetic sensor is operable to detect the magnetic field of the magnet, and wherein the detected magnetic field is indicative of the distance between the anvil and the staple cartridge.
    Type: Application
    Filed: September 5, 2014
    Publication date: March 10, 2016
    Inventors: Daniel L. Baber, Jeffrey S. Swayze, Andrew T. Beckman, Christopher C. Miller, Charles J. Scheib, Jamison J. Float, Matthew E. O'Kelly
  • Publication number: 20120302572
    Abstract: The present invention provides diagnostic methods for assessing the EMT status of tumor cells, and for predicting the effectiveness of treatment of a cancer patient with an EGFR or IGF-1R kinase inhibitor, utilizing an EMT gene signature index score. The present invention further provides methods for treating patients with cancer that incorporate these methods.
    Type: Application
    Filed: April 25, 2012
    Publication date: November 29, 2012
    Applicants: AVEO PHARMACEUTICALS, INC., OSI Pharmaceuticals, LLC
    Inventors: Julie Kan, Stuart Thomson, Gretchen M. Argast, Matthew E. O'Connor, Murray Robinson, Bin Feng, Joerg Heyer, Maria I. Chiu, Richard Nicoletti